Ana-Maria Florescu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Ana-Maria Florescu

Showing results (11-20 of 12) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 12 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023

RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell FunctionAlyssa L Flynn, Joseph Gans, Javier Escobedo, et al.

Nature Cancer|May 1, 2026

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 studyNeeltje Steeghs, Carlos Gomez-Roca, Iphigénie Korakis, et al.

Pageof 2

Search research articles

Showing results (11-20 of 12) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 12 results.

Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2023

RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell FunctionAlyssa L Flynn, Joseph Gans, Javier Escobedo, et al.

Nature Cancer|May 1, 2026

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 studyNeeltje Steeghs, Carlos Gomez-Roca, Iphigénie Korakis, et al.

Pageof 2